Tumor Molecular Profiling in Patients With Prostate Cancer

Plain-language summary

This is an observational study that examines the molecular features of tumors in people with prostate cancer. Patients with metastatic, recurrent, locally advanced or high-risk operable prostate cancer who have tumor tissue available for analysis were included. It is a non-interventional (observational) study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Hellenic Cooperative Oncology Group

Intervention

Tumor molecular profiling

Start date

1/1/2018

Estimated completion

9/1/2022

Countries

Greece

Related genes

Locations

• Athens, Greece

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

Metastatic prostate cancer Recurrent prostate cancer Locally advanced prostate cancer High-risk operable prostate cancer Available FFPE tumor tissue

Exclusion Criteria:

Absence of tumor tissue available for analysis Lack of informed consent Lack of clinicopathological data